% alzhub.org topic: linagliptin
% Source: https://alzhub.org/topic/linagliptin
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{arab2023-37630980,
  author  = {Arab, H. H. and Eid, A. H. and Alsufyani, S. E. and Ashour, A. M. and El-Sheikh, A. A. K. and Darwish, H. W. and Georgy, G. S.},
  title   = {{Neuroprotective Impact of Linagliptin against Cadmium-Induced Cognitive Impairment and Neuropathological Aberrations: Targeting SIRT1/Nrf2 Axis, Apoptosis, and Autophagy}},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  year    = {2023},
  doi     = {10.3390/ph16081065},
  pmid    = {37630980},
  url     = {https://doi.org/10.3390/ph16081065}
}

@article{siddiqui2023-37079222,
  author  = {Siddiqui, N. and Ali, J. and Parvez, S. and Najmi, A. K. and Akhtar, M.},
  title   = {{Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease}},
  journal = {Neurochemical research},
  year    = {2023},
  doi     = {10.1007/s11064-023-03924-w},
  pmid    = {37079222},
  url     = {https://doi.org/10.1007/s11064-023-03924-w}
}

@article{siddiqui2021-34119519,
  author  = {Siddiqui, N. and Ali, J. and Parvez, S. and Zameer, S. and Najmi, A. K. and Akhtar, M.},
  title   = {{Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease}},
  journal = {Neuropharmacology},
  year    = {2021},
  doi     = {10.1016/j.neuropharm.2021.108662},
  pmid    = {34119519},
  url     = {https://doi.org/10.1016/j.neuropharm.2021.108662}
}

@article{wicinski2019-31434198,
  author  = {Wiciński, M. and Górski, K. and Walczak, M. and Wódkiewicz, E. and Słupski, M. and Pawlak-Osińska, K. and Malinowski, B.},
  title   = {{Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases}},
  journal = {International journal of molecular sciences},
  year    = {2019},
  doi     = {10.3390/ijms20164052},
  pmid    = {31434198},
  url     = {https://doi.org/10.3390/ijms20164052}
}

@article{nakaoku2019-31126115,
  author  = {Nakaoku, Y. and Saito, S. and Yamamoto, Y. and Maki, T. and Takahashi, R. and Ihara, M.},
  title   = {{The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice}},
  journal = {International journal of molecular sciences},
  year    = {2019},
  doi     = {10.3390/ijms20102539},
  pmid    = {31126115},
  url     = {https://doi.org/10.3390/ijms20102539}
}

@article{darsalia2019-31139140,
  author  = {Darsalia, V. and Johansen, O. E. and Lietzau, G. and Nyström, T. and Klein, T. and Patrone, C.},
  title   = {{Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke}},
  journal = {Frontiers in neurology},
  year    = {2019},
  doi     = {10.3389/fneur.2019.00493},
  pmid    = {31139140},
  url     = {https://doi.org/10.3389/fneur.2019.00493}
}